DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 64 filers reported holding DEXCOM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22,547,200 | -9.0% | 22,540,000 | -0.0% | 0.00% | 0.0% |
Q1 2024 | $24,764,089 | +8.4% | 22,542,000 | +3.1% | 0.00% | 0.0% |
Q4 2023 | $22,841,354 | +53.3% | 21,872,000 | +38.5% | 0.00% | +33.3% |
Q3 2023 | $14,896,988 | -11.0% | 15,790,000 | +0.7% | 0.00% | 0.0% |
Q2 2023 | $16,746,276 | -4.7% | 15,683,000 | -4.3% | 0.00% | 0.0% |
Q1 2023 | $17,572,825 | -12.6% | 16,391,000 | -11.3% | 0.00% | -25.0% |
Q4 2022 | $20,097,464 | +23.8% | 18,475,000 | +4.8% | 0.00% | +33.3% |
Q3 2022 | $16,237,000 | -17.7% | 17,626,000 | -18.3% | 0.00% | -25.0% |
Q2 2022 | $19,741,000 | -0.4% | 21,574,000 | +24.3% | 0.00% | +33.3% |
Q1 2022 | $19,825,000 | +12.2% | 17,362,000 | +16.6% | 0.00% | 0.0% |
Q4 2021 | $17,668,000 | +58.3% | 14,886,000 | +58.1% | 0.00% | +50.0% |
Q3 2021 | $11,158,000 | +26.5% | 9,416,000 | +11.5% | 0.00% | +100.0% |
Q2 2021 | $8,823,000 | – | 8,448,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PIER 88 INVESTMENT PARTNERS LLC | 16,470,000 | $15,524,625 | 3.87% |
ZAZOVE ASSOCIATES LLC | 22,822,000 | $21,545,000 | 2.24% |
SSI INVESTMENT MANAGEMENT LLC | 17,213,000 | $16,223,252 | 1.33% |
BRAIDWELL LP | 37,500,000 | $35,531,250 | 1.12% |
Liberty Mutual Group Asset Management Inc. | 4,075,000 | $3,841 | 1.07% |
MACKAY SHIELDS LLC | 40,394,000 | $38,237,931 | 1.05% |
SHENKMAN CAPITAL MANAGEMENT INC | 14,313,000 | $13,755,211 | 1.03% |
RWC Asset Management LLP | 13,600,000 | $12,852,680 | 0.84% |
LAFFER TENGLER INVESTMENTS, INC. | 2,564 | $2,427,249 | 0.71% |
Context Capital Management, LLC | 5,000 | $4,714 | 0.38% |